Treatment

PG-102 clinical trials

Active studies that list PG-102 as an intervention or treatment.

3active studies

1recruiting now

2countries represented

14largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 1

ObesityCondition

RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity, PG-102Treatment

Australia1 locations

RANI TherapeuticsSponsor

Updated 2026-04-14 · NCT06891287See eligibility →

Opening soonPhase 2

Type 2 Diabetes Mellitus (T2DM)Condition

PG-102, PlaceboTreatment

Australia1 locations

ProGen. Co., Ltd.Sponsor

Updated 2025-09-23 · NCT07187856See eligibility →

Active, not recruitingPhase 2

Type 2 Diabetes Mellitus (T2DM), Obesity Type 2 Diabetes MellitusCondition

PG-102, PlaceboTreatment

South Korea14 locations

ProGen. Co., Ltd.Sponsor

Updated 2025-07-11 · NCT06712615See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.